$993 Million is the total value of Bronte Capital Management Pty Ltd.'s 28 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 37.5% . Bronte Capital Management Pty Ltd. is a registered-investment adviser.
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BRKB | Buy | BERKSHIRE HATHAWAY INC DELcl b new | $143,486,733 | +5.6% | 409,611 | +2.8% | 14.45% | +10.3% |
GOOGL | ALPHABET INCcap stk cl a | $142,955,521 | +9.3% | 1,092,431 | 0.0% | 14.40% | +14.2% | |
REGN | Buy | REGENERON PHARMACEUTICALS | $116,401,108 | +17.1% | 141,442 | +2.3% | 11.72% | +22.3% |
IBKR | Buy | INTERACTIVE BROKERS GROUP | $72,816,696 | +4.8% | 841,228 | +0.6% | 7.34% | +9.4% |
New | VISA INC-CLASS A SHARES | $66,871,497 | – | 290,733 | +100.0% | 6.74% | – | |
New | VANGUARD INDEX FDSsml cp grw etf | $51,677,779 | – | 241,282 | +100.0% | 5.20% | – | |
HLF | Buy | HERBALIFE NUTRITION LTD | $43,669,323 | +9.3% | 3,121,467 | +3.5% | 4.40% | +14.2% |
PINS | Sell | PINTEREST INCcl a | $37,408,087 | -3.7% | 1,383,947 | -2.6% | 3.77% | +0.5% |
PM | Buy | PHILIP MORRIS INTL INC | $37,404,172 | +40.9% | 404,020 | +48.6% | 3.77% | +47.2% |
FCNCA | Buy | FIRST CTZNS BANCSHARES INC Ncl a | $36,223,485 | +9.0% | 26,247 | +1.4% | 3.65% | +13.8% |
AMZN | Buy | AMAZON COM INC | $36,194,115 | +20.2% | 284,724 | +23.2% | 3.65% | +25.5% |
IBB | Sell | ISHARES TRishares biotech | $34,636,074 | -16.8% | 283,229 | -13.6% | 3.49% | -13.1% |
CTVA | Buy | CORTEVA INC | $31,531,289 | -8.8% | 616,327 | +2.1% | 3.18% | -4.8% |
HIBB | Buy | HIBBETT INC | $28,878,526 | +40.7% | 607,841 | +7.5% | 2.91% | +46.9% |
MTCH | Buy | MATCH GROUP INC NEW | $24,938,727 | +6.0% | 636,598 | +13.2% | 2.51% | +10.7% |
GHC | Buy | GRAHAM HLDGS CO | $14,266,010 | +3.4% | 24,470 | +1.4% | 1.44% | +8.0% |
Buy | SOTERA HEALTH CO | $12,513,783 | -15.1% | 835,366 | +6.8% | 1.26% | -11.3% | |
GOOG | Sell | ALPHABET INCcap stk cl c | $9,197,856 | -24.3% | 69,760 | -30.5% | 0.93% | -20.9% |
SQM | Buy | SOCIEDAD QUIMICA Y MINERA DEspon adr ser b | $9,134,284 | +62.9% | 153,080 | +98.2% | 0.92% | +70.1% |
GIS | Buy | GENERAL MLS INC | $8,882,196 | -15.3% | 138,806 | +1.5% | 0.90% | -11.6% |
New | VANECK ETF TRUSTgold miners etf | $8,012,775 | – | 297,762 | +100.0% | 0.81% | – | |
ATVI | Sell | ACTIVISION BLIZZARD INC | $6,527,415 | -83.6% | 69,715 | -85.2% | 0.66% | -82.9% |
BATH & BODY WORKS INC | $6,442,855 | -9.9% | 190,617 | 0.0% | 0.65% | -5.9% | ||
MDLZ | Sell | MONDELEZ INTL INCcl a | $4,135,893 | -22.0% | 59,595 | -18.1% | 0.42% | -18.6% |
BNTX | BIONTECH SEsponsored ads | $2,552,931 | +0.7% | 23,499 | 0.0% | 0.26% | +4.9% | |
New | VANECK ETF TRUSTjunior gold mine | $2,542,399 | – | 78,883 | +100.0% | 0.26% | – | |
RISKIFIED LTD | $2,298,710 | -7.8% | 513,105 | 0.0% | 0.23% | -3.7% | ||
CTMX | CYTOMX THERAPEUTICS INC | $1,193,566 | -25.0% | 925,245 | 0.0% | 0.12% | -22.1% | |
DBTX | Exit | DECIBEL THERAPEUTICS INC | $0 | – | -154,878 | -100.0% | -0.06% | – |
MO | Exit | ALTRIA GROUP INC | $0 | – | -62,674 | -100.0% | -0.27% | – |
ALB | Exit | ALBEMARLE CORP | $0 | – | -19,306 | -100.0% | -0.42% | – |
STT | Exit | STATE STR CORP | $0 | – | -87,940 | -100.0% | -0.62% | – |
BK | Exit | BANK NEW YORK MELLON CORP | $0 | – | -176,865 | -100.0% | -0.76% | – |
VBK | Exit | VANGUARD INDEX FDSsml cp grw etf | $0 | – | -171,513 | -100.0% | -3.80% | – |
IWM | Exit | ISHARES TRrus 2000 grw etf | $0 | – | -278,400 | -100.0% | -6.52% | – |
V | Exit | VISA INC | $0 | – | -284,917 | -100.0% | -6.53% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-06
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BERKSHIRE HATHAWAY INC DEL | 20 | Q3 2023 | 22.6% |
ALPHABET INC-CL A | 20 | Q3 2023 | 14.4% |
HERBALIFE NUTRITION LTD | 20 | Q3 2023 | 22.0% |
INTERACTIVE BROKERS GROUP | 20 | Q3 2023 | 12.4% |
ALPHABET INC-CL C | 20 | Q3 2023 | 5.7% |
VISA INC-CLASS A SHARES | 19 | Q2 2023 | 16.6% |
CORTEVA NC | 17 | Q3 2023 | 6.2% |
GRAHAM HOLDINGS CO-CLASS B | 13 | Q3 2023 | 2.1% |
REGENERON PHARMACEUTICALS | 12 | Q3 2023 | 13.0% |
STATE STREET CORP | 12 | Q2 2023 | 3.0% |
View Bronte Capital Management Pty Ltd.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
SCHEDULE 13G | 2024-02-13 |
13F-HR | 2024-02-07 |
13F-HR | 2023-11-06 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-03 |
13F-HR/A | 2022-08-08 |
13F-HR | 2022-08-08 |
13F-HR | 2022-05-13 |
View Bronte Capital Management Pty Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.